Pharmaceutical Health Outcomes and Policy
Pharmacy Practice and Translational Research
Diagnostic microbiology and infectious disease
Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis. 2013 Dec; 77(4):324-6.
Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples.
Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW
The Journal of antimicrobial chemotherapy
Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013 Feb; 68(2):438-43.
Treatment of Candida famata bloodstream infections: case series and review of the literature.
Zaki A, Gonzales-Luna AJ, Beyda ND, Lasco T, Garey KW
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy. 2023 06; 43(6):466-472.
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.
Jo J, Tran TT, Beyda ND, Simmons D, Hendrickson JA, Almutairi MS, Alnezary FS, Gonzales-Luna AJ, Septimus EJ, Garey KW
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis. Eur J Clin Microbiol Infect Dis. 2022 Oct; 41(10):1207-1213.
Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis.
Hendrickson JA, Hu C, Aitken SL, Beyda N
Antifungal Resistance: a Concerning Trend for the Present and Future. Curr Infect Dis Rep. 2019 Nov 16; 21(12):47.
Antifungal Resistance: a Concerning Trend for the Present and Future.
Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DP
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Diagn Microbiol Infect Dis. 2019 Nov; 95(3):114861.
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP
Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother. 2019 07 01; 74(7):1904-1910.
Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
Dilworth TJ, Casapao AM, Ibrahim OM, Jacobs DM, Bowers DR, Beyda ND, Mercier RC
Adjuvant ?-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does ?-Lactam Class Matter? Antimicrob Agents Chemother. 2019 03; 63(3).
Adjuvant ?-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does ?-Lactam Class Matter?
Beyda ND, Amadio J, Rodriguez JR, Malinowski K, Garey KW, Wanger A, Ostrosky-Zeichner L
In Vitro Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals. J Clin Microbiol. 2018 08; 56(8).
In Vitro Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals.
Sofjan AK, Musgrove RJ, Beyda ND, Russo HP, Lasco TM, Yau R, Restrepo A, Garey KW
Journal of global antimicrobial resistance
Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist. 2018 12; 15:41-47.
Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA.
Sofjan AK, Mitchell A, Shah DN, Nguyen T, Sim M, Trojcak A, Beyda ND, Garey KW
Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy. J Glob Antimicrob Resist. 2018 09; 14:58-64.
Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy.
Jacobs DM, Dilworth TJ, Beyda ND, Casapao AM, Bowers DR
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study. Antimicrob Agents Chemother. 2018 01; 62(1).
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study.
Casapao AM, Jacobs DM, Bowers DR, Beyda ND, Dilworth TJ, REACH-ID Study Group
Early Administration of Adjuvant ?-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis. Pharmacotherapy. 2017 Nov; 37(11):1347-1356.
Early Administration of Adjuvant ?-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Beyda ND, Liao G, Endres BT, Lewis RE, Garey KW
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates. Antimicrob Agents Chemother. 2015 Sep; 59(9):5405-12.
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.
Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL
The American journal of the medical sciences
Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci. 2015 Apr; 349(4):316-20.
Echinocandin use in hospitalized patients: a multi-institutional study.
Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014 Sep 15; 59(6):819-25.
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW
Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90.
Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics.
Tran TT, Beyda ND, Biehle LR, Cottreau JM, Echevarria K, Musick WL, Perez KK, Schilling AN, Houston Infectious Diseases Network
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Significant publications on infectious diseases pharmacotherapy in 2011. Am J Health Syst Pharm. 2012 Oct 01; 69(19):1671-81.
Significant publications on infectious diseases pharmacotherapy in 2011.
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1086-96.
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.